A new topical delivery system allows curcumin, the main active ingredient of turmeric, to be used for ocular neuroprotection. Medscape Optometry
Tag: Viewpoint
Keep an ‘Eye’ on Curcumin for Ocular Neuroprotection
A new topical delivery system allows curcumin, the main active ingredient of turmeric, to be used for ocular neuroprotection. Medscape Optometry
PCA in Toric IOL Power Calculation: The New Kid on the Block
A new algorithm that incorporates posterior corneal astigmatism into toric intraocular lens power calculations shows promise. Medscape Ophthalmology
Anti-VEGF/PRP Regresses Diabetic Retinopathy
Taking a closer look at PROTEUS, an intriguing study in patients with high-risk proliferative diabetic retinopathy. Medscape Ophthalmology
Cultured Cells May Restore Cornea in Bullous Keratopathy
A look at a small case series from Japan whose impressive, sustained results may signal the arrival of an important new treatment option. Medscape Optometry
‘Promising Option’ for IOP Reduction
A review of the study that led to the recent approval of latanoprostene bunod for open-angle glaucoma and ocular hypertension. Medscape Ophthalmology
Disappointing Results of Boston Keratoprosthesis in Kids
Dr Christopher Rapuano discusses challenges and recent disappointing results associated with Boston keratoprosthesis in children. Medscape Ophthalmology
Solid Outcomes for Femtosecond Laser Cataract Surgery
A new study shows the benefit of femtosecond laser-assisted cataract surgery. Medscape Ophthalmology
Oral and IV Corticosteroids Equivalent for Optic Neuritis
Dr Laurie Barclay on new data comparing the efficacy of different corticosteroid administration routes in a condition that often presents alongside MS. Medscape Neurology
Oral and IV Corticosteroids Equivalent for Optic Neuritis
Dr Laurie Barclay on new data comparing the efficacy of different corticosteroid administration routes in a condition that often presents alongside MS. Medscape Neurology
Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes
A retrospective study finds that a treat-extend-stop protocol using anti-VEGF agents for neovascular age-related macular degeneration is associated with positive long-term outcomes. Medscape Ophthalmology
Self-tonometry: Good Potential but Not Yet Practical
Self-measurement of IOP in patients with glaucoma has intriguing possibilities. But is it realistic? Medscape Optometry
Do Corticosteroids Improve Diabetic Macular Edema Outcomes?
Drs Matt Starr and Sophie Bakri on a randomized trial studying the value of adding intravitreal dexamethasone to anti-VEGF therapy. Medscape Ophthalmology
Questioning a Study Linking Exercise to Increased AMD Risk
Dr Brianne Hobbs highlights the limitations behind a recent study reporting more than 50% increased risk for neovascular AMD in men who vigorously exercise. Medscape Optometry
Is Crosslinked Corneal Donor Tissue Beneficial in PK?
Does donor corneal tissue subjected to crosslinking improve outcomes in patients undergoing penetrating keratoplasty? Dr Christopher Rapuano reviews a randomized study with ‘encouraging results.’ Medscape Ophthalmology
Multifocal IOL Implant: OK After Prior Refractive Surgery?
A study on outcomes of multifocal IOL implantation in patients who had had prior refractive surgery for myopia is reviewed. Medscape Ophthalmology
Minimizing Astigmatism in Cataract Surgery
Is intraoperative aberrometry or intraoperative markerless guidance more effective in helping to achieve low amounts of astigmatism after cataract surgery? Dr Garg reviews a recent study. Medscape Ophthalmology
New Anti-VEGF Agent Brolucizumab Shows Promise for AMD
According to new research, brolucizumab, a new anti-VEGF for neovascular AMD, is noninferior to aflibercept and may offer longer dosing intervals. Medscape Ophthalmology
Avoiding Malpractice in Refractive Surgery
Dr Christopher Rapuano looks at new data on how an avoidable error may be costing ophthalmologists millions. Medscape Ophthalmology
Antibiotics for Viral Conjunctivitis: It’s Still Happening
According to a new study, prescription of antibiotics for viral conjunctivitis continues to be a widespread practice. ‘Sobering’ and ‘discouraging,’ says an optometrist. Medscape Optometry